INFORMACIONES PSIQUIÁTRICAS 244

Informaciones Psiquiátricas 2021 - n.º 244 17 Bibliografía 1. Busse M, Quinn L, Dawes H, Jones C, Kelson M, Poile V, Trubey R, Townson J, Edwards RT, Rosser A, Hood K. Suppor- ting physical activity engagement in people with Huntington's disease (EN- GAGE-HD): study protocol for a rando- mized controlled feasibility trial. Trials 2014; 15: 487. 2. Quinn L, Khalil H, Dawes H, Fritz NE, Kegelmeyer D, Kloos AD, Gillard JW, Busse M, for the Outcome Measures Subgroup of the European Huntington’s Disease Network. Reliability and mini- mal detectable change of physical per- formance measures in individuals with pre-manifest and manifest Huntington Disease. Phys Ther 2013; 93: 942 - 956. 3. Drew CJG, Quinn L, Hamana K, Williams- Thomas R, Marsh L, Dimitropoulou P, Playle R, Griffin BA, Kelson M, Schubert R, Muratori L, Reilmann R, Rosser A, Busse M. Physical Activity and Exercise Outcomes in Huntington Disease (PA- CE-HD): Protocol for a 12-Month Trial Within Cohort Evaluation of a Physical Activity Intervention in People With Huntington Disease. Phys Ther. 2019; 99:1201 - 1210. 4. Quinn L, Hamana K, Kelson M, Dawes H, Collett J, Townson J, Roos R, van der Plas AA, Reilmann R, Frich JC, Rickards H, Ros- ser A, Busse M. A randomized, controlled trial of a multi-modal exercise interven- tion in Huntington's disease. Parkinso- nism Relat Disord 2016; 31: 46 - 52. 5. Quinn L, Debono K, Dawes H, Rosser AE, Nemeth AH, Rickards H, Tabrizi SJ, Quarrell O, Trender-Gerhard I, Kelson MJ, Townson J, Busse M, for the mem- bers of the TRAIN-HD project group. Task-Specific Training in Huntington Disease: A Randomized Controlled Fea- sibility Trial. Phys Ther 2014; 94: 1555 - 1568. 6. Bohlen S, Ekwall C; Hellström K; Ves- terlin H; Björnefur M, Wiklund L, and Reilmann R. Physical therapy in Huntington’s disease – toward objecti- ve assessments? Eur J Neurol 2012; 20: 389 - 393. 7. Mueller SM, Petersen JA, Jung HH. Exercise in Huntington's Disease: Cu- rrent State and Clinical Significance. Tremor Other Hyperkinet Mov (NY). 2019; 9: 601. 8. Playle R, Dimitropoulou P, Kelson M, Quinn L, Busse M. Exercise Interven- tions in Huntington's Disease: An Indi- vidual Patient Data Meta-Analysis. Mov Disord Clin Pract 2019; 6: 567 - 575. 9. Quinn L, Kegelmeyer D, Kloos A, Rao AK, Busse M, Fritz NE. Clinical recom- mendations to guide physical therapy practice for Huntington disease. Neuro- logy 2020; 94: 217-228. 10. Huntington Study Group. Unified Huntington’s Disease Rating Scale: re- liability and consistency. Mov Disord 1996; 11: 136 - 142. 11. Garcia de Yebenes J, Landwehrmeyer B, Squitieri F, Reilmann R, Rosser A, Barker RA, Saft C, Magnet MK, Sword A, Rem- bratt A, Tedroff J. Pridopidine for the treatment of motor function in patients ESCALA DE VALORACIÓN DEL CONTROL CONSCIENTE DEL MOVIMIENTO EN LA ENFERMEDAD DE HUNTINGTON (CCM - HD).